PE-backed Paragon Bioservices beefs up team with new hire

Baltimore-based Paragon Bioservices, a producer of biopharmaceuticals and vaccines, has named Deborah Wild as vice president of quality and regulatory affairs. Previously, Wild ran a consulting practice where she led quality assurance initiatives for clients such as Genentech, TEVA, Cytovance and CMC Biologics. Paragon is backed by NewSpring Capital and Camden Partners.

PeopleNorth AmericaUSBriefs